NCT02128828View on ClinicalTrials.gov

Effect of Cenicriviroc on HIV Neurocognitive Impairment

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
AIDS Dementia ComplexHIV-1-Associated Cognitive Motor ComplexHuman Immunodeficiency Virus
Interventions
DRUG

cenicriviroc

cenicriviroc given once daily for 24 weeks; number of pills dependent on recommended modifications based on patient's other antiretroviral medications and certain other medications anticipated to interact with cenicriviroc

Trial Locations (1)

96813

Clint Spencer Clinic, Honolulu

All Listed Sponsors
collaborator

Tobira Therapeutics, Inc.

INDUSTRY

lead

University of Hawaii

OTHER

NCT02128828 - Effect of Cenicriviroc on HIV Neurocognitive Impairment | Biotech Hunter | Biotech Hunter